Keryx Biopharmaceuticals Inc. (Nasdaq: KERX) posted positive results for its drug candidate to treat dialysis patients sending the stock price soaring 54 cents to $2.90.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.